Medtronic (MDT) Change in Receivables (2014 - 2026)

Medtronic (MDT) has 13 years of Change in Receivables data on file, last reported at $287.0 million in Q2 2026.

• For the quarter ending Q2 2026, Change in Receivables rose 15.26% year-over-year to $287.0 million; the trailing twelve-month figure through Apr 2026 stood at $200.0 million (down 53.81% YoY), and the FY2026 full-year result was $200.0 million, down 53.81% from the prior year.
• Change in Receivables improved to $287.0 million in Q2 2026, from -$13.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $435.0 million in Q4 2022 to a low of -$288.0 million in Q3 2025.
• A 5-year average of $105.9 million and a median of $115.0 million in 2023 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables jumped 232.06% in 2022 and slumped 533.33% in 2026, its largest moves.
• Tracing MDT's Change in Receivables over 5 years: stood at $435.0 million in 2022, then tumbled by 35.4% to $281.0 million in 2023, then grew by 3.56% to $291.0 million in 2024, then declined by 26.46% to $214.0 million in 2025, then jumped by 34.11% to $287.0 million in 2026.
• Business Quant data shows MDT's Change in Receivables at $287.0 million in Q2 2026, -$13.0 million in Q1 2026, and $214.0 million in Q4 2025.